colforsin has been researched along with alitretinoin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Bandoh, S; Maruyama, K; Ohkura, N; Sasaki, K; Tsukada, T; Yamaguchi, K | 1 |
| Brent, GA; Huang, M; Johnson, LS; Kogai, T; Schultz, JJ | 1 |
| Harigaya, T; Katayama, M; Kawamura, K; Matsubara, M; Nogami, H | 1 |
| Denis, M; Genest, J; Haidar, B; Krimbou, L; Marcil, M | 1 |
| Convertini, P; Iacobazzi, V; Infantino, V; Palmieri, F; Scarcia, P; Todisco, S | 1 |
6 other study(ies) available for colforsin and alitretinoin
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Retinoic acids differentially regulate NOR-1 and its closely related orphan nuclear receptor genes in breast cancer cell line MCF-7.
Topics: Alitretinoin; Breast Neoplasms; Colforsin; Cycloheximide; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Nerve Tissue Proteins; Nuclear Receptor Subfamily 4, Group A, Member 1; Nuclear Receptor Subfamily 4, Group A, Member 2; Receptors, Cytoplasmic and Nuclear; Receptors, Steroid; Receptors, Thyroid Hormone; RNA, Messenger; Tetradecanoylphorbol Acetate; Transcription Factors; Tretinoin; Tumor Cells, Cultured | 1997 |
Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line.
Topics: Alitretinoin; Animals; Antineoplastic Agents; Breast Neoplasms; Carrier Proteins; Cell Line; Colforsin; Down-Regulation; Female; Humans; Iodides; Iodine Radioisotopes; Kinetics; Membrane Proteins; Oxytocin; Prolactin; Rats; Sodium Iodide; Symporters; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured | 2000 |
Retinoic acids and thyroid hormone act synergistically with dexamethasone to increase growth hormone-releasing hormone receptor messenger ribonucleic acid expression.
Topics: Alitretinoin; Animals; Colforsin; Cyclic AMP; Dexamethasone; Drug Synergism; Estradiol; Gene Expression; Glucocorticoids; Growth Hormone-Releasing Hormone; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide; Receptors, Pituitary Hormone-Regulating Hormone; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tretinoin; Triiodothyronine | 2000 |
Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter.
Topics: Alitretinoin; Alleles; Animals; Apolipoprotein A-I; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Biotinylation; Catalytic Domain; Cell Membrane; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; Humans; Hydroxycholesterols; Isoquinolines; Lipid Metabolism; Mutation; Phosphorylation; Precipitin Tests; Protein Binding; Signal Transduction; Sulfonamides; Tangier Disease; Time Factors; Transfection; Tretinoin | 2004 |
Statins, fibrates and retinoic acid upregulate mitochondrial acylcarnitine carrier gene expression.
Topics: Alitretinoin; Animals; Anticholesteremic Agents; Carnitine; Clofibric Acid; Colforsin; Gene Expression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Membrane Transport Proteins; Mitochondria; PPAR alpha; Promoter Regions, Genetic; Rats; Tretinoin | 2009 |